Monthly Archives: February 2021

Analysts Offer Insights on Healthcare Companies: Crispr Therapeutics AG (NASDAQ: CRSP) and Alector (NASDAQ: ALEC)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Crispr Therapeutics AG (CRSP – Research Report) and Alector (ALEC – Research Report) with bullish sentiments. Crispr Therapeutics AG (CRSP) Barclays analyst

B.Riley Financial Keeps a Buy Rating on Marcus (MCS)

In a report issued on February 23, Eric Wold from B.Riley Financial maintained a Buy rating on Marcus (MCS – Research Report), with a price target of $25.00. The company’s shares closed last Friday at $19.64. According to TipRanks.com, Wold

Assembly Biosciences (ASMB) Receives a Buy from Robert W. Baird

In a report issued on February 26, Brian Skorney from Robert W. Baird maintained a Buy rating on Assembly Biosciences (ASMB – Research Report). The company’s shares closed last Friday at $5.08, close to its 52-week low of $4.78. According

Robert W. Baird Believes Donaldson Company (NYSE: DCI) Won’t Stop Here

Robert W. Baird analyst Richard Eastman maintained a Buy rating on Donaldson Company (DCI – Research Report) on February 25. The company’s shares closed last Friday at $58.91, close to its 52-week high of $62.70. According to TipRanks.com, Eastman is

Terminix Global Holdings (TMX) Gets a Buy Rating from Robert W. Baird

In a report issued on February 25, Andrew Wittmann from Robert W. Baird reiterated a Buy rating on Terminix Global Holdings (TMX – Research Report). The company’s shares closed last Friday at $45.01. According to TipRanks.com, Wittmann is a 5-star

Robert W. Baird Reiterates Their Buy Rating on California Water Service (CWT)

Robert W. Baird analyst Ben Kallo reiterated a Buy rating on California Water Service (CWT – Research Report) on February 25. The company’s shares closed last Friday at $54.95. Kallo has an average return of 2.6% when recommending California Water